GONELLA JACQUES
Insider CIK 1189296 · AIS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-02-26 | 2019-02-28 | 200,000 | $3.65 | $730.0K | 9,385,848 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-10-02 | 2018-10-04 | 400,000 | $3.79 | $1.52M | 9,585,848 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-08-13 | 2018-08-15 | 49,507 | $3.09 | $153.0K | 9,985,848 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-08-08 | 2018-08-10 | 250,493 | $3.09 | $774.0K | 10,035,355 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-15 | 2018-06-20 | 565 | $2.95 | $1.7K | 10,285,848 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-12 | 2018-06-13 | 100,000 | $2.77 | $277.0K | 10,286,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-11 | 2018-06-13 | 100,000 | $2.69 | $269.0K | 10,386,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 76,548 | — | $0 | 76,548 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-06 | 2018-06-07 | 20,259 | $2.70 | $54.7K | 10,486,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-05 | 2018-06-05 | 100,000 | $2.55 | $255.0K | 10,529,801 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-05 | 2018-06-07 | 23,129 | $2.70 | $62.4K | 10,506,672 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-04 | 2018-06-05 | 100,000 | $2.65 | $265.0K | 10,629,801 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-01 | 2018-06-01 | 78,938 | $2.60 | $205.2K | 10,786,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-06-01 | 2018-06-05 | 56,612 | $2.70 | $152.9K | 10,729,801 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-30 | 2018-06-01 | 100,000 | $2.55 | $255.0K | 10,865,351 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-23 | 2018-05-24 | 100,000 | $2.50 | $250.0K | 10,965,351 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-23 | 2018-05-24 | 94,682 | $2.53 | $239.5K | 11,065,351 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-22 | 2018-05-24 | 5,318 | $2.53 | $13.5K | 11,160,033 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-18 | 2018-05-22 | 21,062 | $2.60 | $54.8K | 11,165,351 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-17 | 2018-05-18 | 100,000 | $2.55 | $255.0K | 11,186,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-16 | 2018-05-18 | 100,000 | $2.52 | $252.0K | 11,286,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-15 | 2018-05-16 | 100,000 | $2.50 | $250.0K | 11,386,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-14 | 2018-05-16 | 100,000 | $2.50 | $250.0K | 11,486,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-11 | 2018-05-14 | 100,000 | $2.47 | $247.0K | 11,586,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-10 | 2018-05-14 | 100,000 | $2.36 | $236.0K | 11,686,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-09 | 2018-05-11 | 150,000 | $2.46 | $369.0K | 11,936,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-05-09 | 2018-05-11 | 150,000 | $2.47 | $370.5K | 11,786,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2018-05-03 | 2018-05-07 | 30,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2018-05-03 | 2018-05-07 | 30,000 | $0.85 | $25.5K | 12,086,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 80,318 | — | $0 | 80,318 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-03-31 | 2017-04-04 | 30,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-03-31 | 2017-04-04 | 30,000 | $1.65 | $49.5K | 12,056,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | J Other | 2016-12-30 | 2017-01-12 | 2,900,000 | — | $0 | 12,026,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-18 | 2016-03-21 | 100,000 | $0.72 | $72.0K | 9,126,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2015-12-16 | 2015-12-18 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2015-12-16 | 2015-12-18 | 20,000 | $1.54 | $30.8K | 9,026,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 99,395 | — | $0 | 99,395 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-12-30 | 2015-01-14 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-12-30 | 2015-01-14 | 20,000 | $1.40 | $28.0K | 9,006,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 61,930 | — | $0 | 311,930 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 1,250 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 1,250 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-14 | 2014-01-14 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 2,000 | $1.01 | $2.0K | 8,981,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 500 | $1.32 | $660 | 8,979,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 2,000 | $1.40 | $2.8K | 8,978,913 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 2,000 | $1.10 | $2.2K | 8,976,913 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 1,250 | $1.40 | $1.8K | 8,986,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 1,250 | $0.70 | $875 | 8,985,163 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 2,000 | $0.90 | $1.8K | 8,983,913 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-14 | 2014-01-14 | 500 | $0.95 | $475 | 8,981,913 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-10-07 | 2013-10-09 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-10-07 | 2013-10-09 | 20,500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-10-07 | 2013-10-09 | 7,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-10-07 | 2013-10-09 | 7,000 | $1.30 | $9.1K | 8,953,913 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-10-07 | 2013-10-09 | 500 | $1.13 | $565 | 8,954,413 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-10-07 | 2013-10-09 | 20,500 | $1.06 | $21.7K | 8,974,913 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 27,778 | — | $0 | 8,946,913 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-12-11 | 2012-12-13 | 5,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-12-11 | 2012-12-13 | 5,000 | $1.50 | $7.5K | 8,919,135 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award | 2012-05-17 | 2012-05-21 | 30,914 | — | $0 | 8,914,135 | SEC↗ |